ABVC BioPharma, Inc.
ABVC
$1.33
$0.043.10%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/4/2026
-
Ticker Report
12/30/2025
-
MarketBeat
12/9/2025
-
Ticker Report
11/26/2025
-
MarketBeat
11/4/2025
-
Ticker Report
10/25/2025
-
MarketBeat
10/23/2025
-
Ticker Report
10/8/2025
-
MarketBeat
10/1/2025
-
MarketBeat
9/21/2025
-
Insider Monkey
8/15/2025
-
MarketBeat
8/14/2025
-
GuruFocus
8/14/2025
-
Fool.com Headlines
8/8/2025
-
MarketBeat
7/8/2025
-
Market News Video
6/4/2025
-
TipRanks Financial Blog
6/3/2025
-
Ticker Report
5/22/2025
-
GuruFocus
5/22/2025
-
TipRanks Financial Blog
5/22/2025
-
The Fly
5/1/2025
-
GuruFocus
4/16/2025
-
GuruFocus
4/15/2025
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, March 3, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of Apr 13 and 17 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
510 668 0881
Address
44370 Old Warm Springs Boulevard
Fremont, CA 94538
Fremont, CA 94538
Country
Year Founded
--
Business Description
Sector
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which...
more